Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Non-Small-Cell Lung | 21 | 2024 | 5319 | 1.510 |
Why?
|
| Lung Neoplasms | 21 | 2024 | 11538 | 1.060 |
Why?
|
| Radiation Pneumonitis | 7 | 2018 | 301 | 0.820 |
Why?
|
| Proton Therapy | 6 | 2024 | 1577 | 0.790 |
Why?
|
| Chemoradiotherapy | 7 | 2022 | 1946 | 0.740 |
Why?
|
| Butyrates | 1 | 2017 | 57 | 0.600 |
Why?
|
| Hyperalgesia | 1 | 2017 | 238 | 0.510 |
Why?
|
| Esophagitis | 1 | 2014 | 202 | 0.460 |
Why?
|
| Vincristine | 1 | 2017 | 1511 | 0.450 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 1538 | 0.400 |
Why?
|
| Radiotherapy, Intensity-Modulated | 5 | 2020 | 2104 | 0.370 |
Why?
|
| NF-kappa B | 1 | 2017 | 1549 | 0.370 |
Why?
|
| Pericardial Effusion | 2 | 2020 | 118 | 0.310 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2018 | 142 | 0.300 |
Why?
|
| Radiation Injuries | 3 | 2020 | 1411 | 0.280 |
Why?
|
| Inflammation | 1 | 2014 | 2522 | 0.250 |
Why?
|
| Heart | 3 | 2023 | 1223 | 0.250 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2018 | 4549 | 0.200 |
Why?
|
| MicroRNAs | 1 | 2014 | 2947 | 0.190 |
Why?
|
| Lung | 3 | 2022 | 3151 | 0.190 |
Why?
|
| Signal Transduction | 1 | 2017 | 11965 | 0.170 |
Why?
|
| Aged | 19 | 2024 | 70117 | 0.170 |
Why?
|
| Hepcidins | 1 | 2018 | 34 | 0.160 |
Why?
|
| Radiotherapy, Image-Guided | 2 | 2017 | 304 | 0.160 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2024 | 3890 | 0.150 |
Why?
|
| Tumor Burden | 3 | 2018 | 1987 | 0.150 |
Why?
|
| Aged, 80 and over | 14 | 2018 | 29902 | 0.150 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2018 | 292 | 0.150 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2017 | 101 | 0.150 |
Why?
|
| Smad4 Protein | 1 | 2018 | 196 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2015 | 32 | 0.140 |
Why?
|
| Re-Irradiation | 1 | 2017 | 163 | 0.140 |
Why?
|
| Nomograms | 1 | 2018 | 313 | 0.130 |
Why?
|
| Pneumonectomy | 1 | 2020 | 831 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2020 | 10035 | 0.120 |
Why?
|
| Administration, Oral | 1 | 2017 | 1544 | 0.110 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2013 | 33 | 0.110 |
Why?
|
| Retrospective Studies | 9 | 2024 | 37905 | 0.110 |
Why?
|
| Radiotherapy Dosage | 5 | 2020 | 3842 | 0.110 |
Why?
|
| Humans | 23 | 2024 | 261506 | 0.110 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 852 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 2063 | 0.110 |
Why?
|
| Male | 18 | 2020 | 123000 | 0.110 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 799 | 0.110 |
Why?
|
| Peptide Fragments | 1 | 2018 | 1271 | 0.110 |
Why?
|
| Middle Aged | 16 | 2020 | 86204 | 0.100 |
Why?
|
| Breast | 1 | 2018 | 1344 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 4892 | 0.100 |
Why?
|
| Risk | 4 | 2018 | 1972 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1217 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2024 | 3341 | 0.090 |
Why?
|
| Adult | 13 | 2018 | 77950 | 0.090 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 629 | 0.090 |
Why?
|
| Female | 18 | 2020 | 141928 | 0.090 |
Why?
|
| Smoking | 1 | 2018 | 2440 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 1439 | 0.080 |
Why?
|
| Proportional Hazards Models | 4 | 2018 | 4988 | 0.080 |
Why?
|
| Rats | 1 | 2017 | 6086 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2018 | 2967 | 0.070 |
Why?
|
| Genotype | 4 | 2018 | 4109 | 0.070 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 3 | 2023 | 2370 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2012 | 1171 | 0.070 |
Why?
|
| Treatment Failure | 2 | 2018 | 1391 | 0.060 |
Why?
|
| Risk Factors | 3 | 2018 | 17523 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 7222 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 5437 | 0.060 |
Why?
|
| Biomarkers | 1 | 2014 | 5047 | 0.060 |
Why?
|
| Logistic Models | 2 | 2020 | 3441 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2018 | 2316 | 0.050 |
Why?
|
| Organs at Risk | 1 | 2023 | 514 | 0.050 |
Why?
|
| Prognosis | 4 | 2020 | 21713 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2020 | 12873 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 4298 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2014 | 2307 | 0.040 |
Why?
|
| Biomarkers, Tumor | 2 | 2018 | 10331 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 319 | 0.040 |
Why?
|
| Scattering, Radiation | 1 | 2018 | 316 | 0.040 |
Why?
|
| Incidence | 2 | 2018 | 5673 | 0.040 |
Why?
|
| Relative Biological Effectiveness | 1 | 2017 | 219 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2018 | 482 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2020 | 1014 | 0.030 |
Why?
|
| Protons | 1 | 2018 | 473 | 0.030 |
Why?
|
| Carboplatin | 1 | 2018 | 823 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 9180 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 6009 | 0.030 |
Why?
|
| Fibrosis | 1 | 2018 | 793 | 0.030 |
Why?
|
| Photons | 1 | 2018 | 507 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 5539 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 15694 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 14889 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2018 | 1021 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2015 | 403 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2018 | 2231 | 0.030 |
Why?
|
| Mastectomy, Segmental | 1 | 2018 | 1026 | 0.030 |
Why?
|
| Radiometry | 1 | 2018 | 980 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 13658 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2014 | 684 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 700 | 0.030 |
Why?
|
| Animals | 1 | 2017 | 59536 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2013 | 264 | 0.030 |
Why?
|
| Pneumonia | 1 | 2017 | 751 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2018 | 1996 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 311 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2018 | 1824 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2018 | 2086 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 4844 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 12221 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 6682 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2018 | 32848 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2016 | 2576 | 0.010 |
Why?
|
| Algorithms | 1 | 2014 | 3890 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 12926 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 21445 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2012 | 6869 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 4557 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 14289 | 0.010 |
Why?
|